WCM
NVO

Wealthcare Capital Management’s Novo Nordisk NVO Stock Holding History

Wealthcare Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-256
Closed -$7K – 517
2019
Q4 		$7K Buy
+256
New +$7.09K ﹤0.01% 217
2015
Q2 		– Sell
-774
Closed -$21K – 719
2015
Q1 		$21K Buy
+774
New +$17.8K ﹤0.01% 394

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Wealthcare Capital Management's NVO Position: Q1 2020 in Review

Wealthcare Capital Management sold out of Novo Nordisk (NVO) in Q1 2020, closing a stake of 256 shares — an estimated $7K sold.

Wealthcare Capital Management first reported a position in NVO in Q1 2015 and held it in 2 quarters. The position peaked at $21K in Q1 2015. 644 funds tracked by Wall St. Rank hold NVO as of Q1 2020.

  • Wealthcare Capital Management reported no remaining Novo Nordisk position as of Q1 2020 after selling out during the quarter.
  • Wealthcare Capital Management sold 256 Novo Nordisk shares in Q1 2020, an estimated $7K.
  • Wealthcare Capital Management first reported a position in Novo Nordisk in Q1 2015 and held it in 2 quarters.
  • Wealthcare Capital Management's Novo Nordisk position peaked at $21K in Q1 2015.
  • 644 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2020.

Based on Wealthcare Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.